• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.痛风患者痛风发作与随后心血管事件的关系。
JAMA. 2022 Aug 2;328(5):440-450. doi: 10.1001/jama.2022.11390.
2
Risk of Venous Thromboembolism With Gout Flares.痛风发作与静脉血栓栓塞风险。
Arthritis Rheumatol. 2023 Sep;75(9):1638-1647. doi: 10.1002/art.42480. Epub 2023 Jun 15.
3
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂在复发性痛风发作和痛风急诊就诊和住院方面的疗效比较:一项普通人群队列研究。
Ann Intern Med. 2023 Aug;176(8):1067-1080. doi: 10.7326/M23-0724. Epub 2023 Jul 25.
4
Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events.先前颅内出血与主要不良心血管事件的关联。
JAMA Netw Open. 2022 Oct 3;5(10):e2234215. doi: 10.1001/jamanetworkopen.2022.34215.
5
Serum Urate and Recurrent Gout.血清尿酸与复发性痛风
JAMA. 2024 Feb 6;331(5):417-424. doi: 10.1001/jama.2023.26640.
6
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.痛风和糖尿病患者使用别嘌醇与急性心血管事件风险
BMC Cardiovasc Disord. 2017 Mar 14;17(1):76. doi: 10.1186/s12872-017-0513-6.
7
Short-Term Risk of Cardiovascular Events in People Newly Diagnosed With Gout.新诊断痛风患者心血管事件的短期风险
Arthritis Rheumatol. 2025 Feb;77(2):202-211. doi: 10.1002/art.42986. Epub 2024 Oct 17.
8
COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.COVID-19 疫苗接种与痛风发作风险:一项频发或偶发发作患者的前瞻性队列研究。
Arthritis Care Res (Hoboken). 2024 Jan;76(1):131-139. doi: 10.1002/acr.25215. Epub 2023 Nov 9.
9
Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.膳食和补充ω-3 多不饱和脂肪酸对复发性痛风发作风险的影响。
Arthritis Rheumatol. 2019 Sep;71(9):1580-1586. doi: 10.1002/art.40896. Epub 2019 Aug 1.
10
Hyperuricemia and intravenous fat emulsion are risk factors for gout flares during active gastrointestinal bleeding: a case control study.高尿酸血症和静脉用脂肪乳剂是活动性胃肠道出血期间痛风发作的危险因素:一项病例对照研究。
Adv Rheumatol. 2024 May 3;64(1):37. doi: 10.1186/s42358-024-00376-w.

引用本文的文献

1
Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul.韩国心血管代谢综合征学会(KSCMS)与日本高血压学会(JSH)在首尔举行的第8届亚太心血管代谢综合征(APCMS)大会上的联合研讨会报告。
Hypertens Res. 2025 Jul 29. doi: 10.1038/s41440-025-02310-z.
2
Uric Acid, Colchicine and Chronic Inflammatory Diseases: A Cardiovascular Perspective.尿酸、秋水仙碱与慢性炎症性疾病:心血管视角
Metabolites. 2025 Jun 20;15(7):424. doi: 10.3390/metabo15070424.
3
Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial.祛湿通痹方用于降低降尿酸治疗相关痛风发作:一项多中心、随机、双盲、安慰剂平行对照临床试验的研究方案
PLoS One. 2025 Jul 9;20(7):e0327864. doi: 10.1371/journal.pone.0327864. eCollection 2025.
4
Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system.使用美国食品药品监督管理局不良事件报告系统评估药物性高尿酸血症和痛风风险。
Sci Rep. 2025 Jul 2;15(1):22856. doi: 10.1038/s41598-025-06114-6.
5
Exploring the Impact of the Gut Microbiota/REV-ERBα/NF-κB Axis on the Circadian Rhythmicity of Gout Flares from a Chronobiological Perspective.从生物钟学角度探讨肠道微生物群/REV-ERBα/核因子κB轴对痛风发作昼夜节律的影响。
J Inflamm Res. 2025 Jun 19;18:8141-8151. doi: 10.2147/JIR.S525351. eCollection 2025.
6
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and gout in US adults: a cross-sectional study of the mediating role of BMI.美国成年人中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与痛风之间的关联:一项关于BMI中介作用的横断面研究
Diabetol Metab Syndr. 2025 Jun 18;17(1):223. doi: 10.1186/s13098-025-01798-2.
7
Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study.全膝关节置换术后不同VTE预防药物对血红蛋白水平影响的比较:一项基于医院信息系统的观察性研究
J Orthop Surg Res. 2025 Jun 16;20(1):589. doi: 10.1186/s13018-025-06004-7.
8
Acupuncture as an Adjunctive Therapy to Etoricoxib for Patients with Acute Gouty Arthritis: Protocol for a Multicenter Randomized Controlled Trial.针灸作为依托考昔辅助治疗急性痛风性关节炎患者的研究:一项多中心随机对照试验方案
J Pain Res. 2025 Jun 9;18:2889-2900. doi: 10.2147/JPR.S523657. eCollection 2025.
9
The effects of GLUT9 and URAT1 inhibitors on cardiovascular diseases: a drug-targeted Mendelian randomization study.葡萄糖转运蛋白9(GLUT9)和尿酸转运蛋白1(URAT1)抑制剂对心血管疾病的影响:一项药物靶向孟德尔随机化研究
Int Urol Nephrol. 2025 Jun 6. doi: 10.1007/s11255-025-04594-z.
10
Exploring Therapeutic Potential of Bi-Qi Capsules in Treatment of Gout by Discovering Crucial Drug Targets.通过发现关键药物靶点探索痹祺胶囊治疗痛风的潜在疗效
Pharmaceuticals (Basel). 2025 Apr 24;18(5):618. doi: 10.3390/ph18050618.

本文引用的文献

1
Gout.痛风。
Lancet. 2021 May 15;397(10287):1843-1855. doi: 10.1016/S0140-6736(21)00569-9. Epub 2021 Mar 30.
2
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
3
Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study.英国初级和二级医疗保健数据集中风记录的一致性:一项基于人群的队列研究。
BJGP Open. 2021 Apr 26;5(2). doi: 10.3399/BJGPO.2020.0117. Print 2021 Apr.
4
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.炎症性关节炎中的心血管风险:类风湿关节炎和痛风
Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1.
5
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.全球痛风流行病学:患病率、发病率、治疗模式和危险因素。
Nat Rev Rheumatol. 2020 Jul;16(7):380-390. doi: 10.1038/s41584-020-0441-1. Epub 2020 Jun 15.
6
Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea.韩国一项前瞻性多中心研究:痛风发作的季节性变化及相关因素。
J Korean Med Sci. 2020 May 25;35(20):e133. doi: 10.3346/jkms.2020.35.e133.
7
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
8
Acute Infection and Myocardial Infarction.急性感染与心肌梗死
N Engl J Med. 2019 Jan 10;380(2):171-176. doi: 10.1056/NEJMra1808137.
9
Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.当代美国痛风和高尿酸血症的流行情况及十年趋势:2007-2016 年国家健康和营养调查。
Arthritis Rheumatol. 2019 Jun;71(6):991-999. doi: 10.1002/art.40807. Epub 2019 Apr 15.
10
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

痛风患者痛风发作与随后心血管事件的关系。

Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.

机构信息

Academic Rheumatology, University of Nottingham, Nottingham, United Kingdom.

Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

出版信息

JAMA. 2022 Aug 2;328(5):440-450. doi: 10.1001/jama.2022.11390.

DOI:10.1001/jama.2022.11390
PMID:35916846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346550/
Abstract

IMPORTANCE

Gout is associated with cardiovascular diseases. The temporal association between gout flares and cardiovascular events has not been investigated.

OBJECTIVE

To investigate whether there is a transient increase in risk of cardiovascular events after a recent gout flare.

DESIGN, SETTING, AND PARTICIPANTS: A retrospective observational study was conducted using electronic health records from the Clinical Practice Research Datalink in England between January 1, 1997, and December 31, 2020. A multivariable nested case-control study was performed among 62 574 patients with gout, and a self-controlled case series, adjusted for season and age, was performed among 1421 patients with gout flare and cardiovascular event.

EXPOSURES

Gout flares were ascertained using hospitalization, primary care outpatient, and prescription records.

MAIN OUTCOMES AND MEASURES

The primary outcome was a cardiovascular event, defined as an acute myocardial infarction or stroke. Association with recent prior gout flares was measured using adjusted odds ratios (ORs) with 95% CIs in a nested case-control study and adjusted incidence rate ratios (IRRs) with 95% CIs in a self-controlled case series.

RESULTS

Among patients with a new diagnosis of gout (mean age, 76.5 years; 69.3% men, 30.7% women), 10 475 patients with subsequent cardiovascular events were matched with 52 099 patients without cardiovascular events. Patients with cardiovascular events, compared with those who did not have cardiovascular events, had significantly higher odds of gout flare within the prior 0 to 60 days (204/10 475 [2.0%] vs 743/52 099 [1.4%]; adjusted OR, 1.93 [95% CI, 1.57-2.38]) and within the prior 61 to 120 days (170/10 475 [1.6%] vs 628/52 099 [1.2%]; adjusted OR, 1.57 [95% CI, 1.26-1.96]). There was no significant difference in the odds of gout flare within the prior 121 to 180 days (148/10 475 [1.4%] vs 662/52 099 [1.3%]; adjusted OR, 1.06 [95% CI, 0.84-1.34]). In the self-controlled case series (N = 1421), cardiovascular event rates per 1000 person-days were 2.49 (95% CI, 2.16-2.82) within days 0 to 60; 2.16 (95% CI, 1.85-2.47) within days 61 to 120; and 1.70 (95% CI, 1.42-1.98) within days 121 to 180 after a gout flare, compared with cardiovascular event rates of 1.32 (95% CI, 1.23-1.41) per 1000 person-days within the 150 days before or the 181 to 540 days after the gout flare. Compared with 150 days before or the 181 to 540 days after a gout flare, incidence rate differences for cardiovascular events were 1.17 (95% CI, 0.83-1.52) per 1000 person-days, and adjusted IRRs were 1.89 (95% CI, 1.54-2.30) within days 0 to 60; 0.84 (95% CI, 0.52-1.17) per 1000 person-days and 1.64 (95% CI, 1.45-1.86) within days 61 to 120; and 0.38 (95% CI, 0.09-0.67) per 1000 person-days and 1.29 (95% CI, 1.02-1.64) within days 121 to 180 after a gout flare.

CONCLUSIONS AND RELEVANCE

Among individuals with gout, those who experienced a cardiovascular event, compared with those who did not experience such an event, had significantly higher odds of a recent gout flare in the preceding days. These findings suggest gout flares are associated with a transient increase in cardiovascular events following the flare.

摘要

重要性

痛风与心血管疾病有关。痛风发作与心血管事件之间的时间关联尚未被研究。

目的

调查近期痛风发作后是否存在心血管事件风险的短暂增加。

设计、设置和参与者:这是一项使用英格兰临床实践研究数据链(Clinical Practice Research Datalink)在 1997 年 1 月 1 日至 2020 年 12 月 31 日之间进行的回顾性观察性研究。在 62574 例痛风患者中进行了多变量嵌套病例对照研究,在 1421 例痛风发作和心血管事件患者中进行了调整季节和年龄的自我对照病例系列研究。

暴露

通过住院、初级保健门诊和处方记录确定痛风发作。

主要结果和措施

主要结局为急性心肌梗死或中风的心血管事件。在嵌套病例对照研究中,使用调整后的优势比(OR)和 95%置信区间(CI)测量与近期既往痛风发作的关联,在自我对照病例系列研究中,使用调整后的发病率比(IRR)和 95%CI 测量与近期既往痛风发作的关联。

结果

在新诊断为痛风的患者中(平均年龄为 76.5 岁;69.3%为男性,30.7%为女性),10475 例随后发生心血管事件的患者与 52099 例无心血管事件的患者相匹配。与未发生心血管事件的患者相比,发生心血管事件的患者在痛风发作前 0 至 60 天(204/10475[2.0%]与 743/52099[1.4%];调整后的 OR,1.93[95%CI,1.57-2.38])和痛风发作前 61 至 120 天(170/10475[1.6%]与 628/52099[1.2%];调整后的 OR,1.57[95%CI,1.26-1.96])发生痛风发作的可能性明显更高。在痛风发作前 121 至 180 天(148/10475[1.4%]与 662/52099[1.3%];调整后的 OR,1.06[95%CI,0.84-1.34])发生痛风发作的可能性没有显著差异。在自我对照病例系列研究(N=1421)中,心血管事件发生率在痛风发作后第 0 至 60 天为 2.49(95%CI,2.16-2.82)/1000 人日;在第 61 至 120 天为 2.16(95%CI,1.85-2.47)/1000 人日;在第 121 至 180 天为 1.70(95%CI,1.42-1.98)/1000 人日,而在痛风发作前 150 天或发作后 181 至 540 天内的心血管事件发生率为 1.32(95%CI,1.23-1.41)/1000 人日。与痛风发作前 150 天或发作后 181 至 540 天相比,心血管事件的发生率差异为 1.17(95%CI,0.83-1.52)/1000 人日,调整后的发病率比为 1.89(95%CI,1.54-2.30)/1000 人日;第 0 至 60 天;0.84(95%CI,0.52-1.17)/1000 人日和 1.64(95%CI,1.45-1.86)/1000 人日;第 61 至 120 天;和 0.38(95%CI,0.09-0.67)/1000 人日和 1.29(95%CI,1.02-1.64)/1000 人日。

结论和相关性

在痛风患者中,与未发生此类事件的患者相比,发生心血管事件的患者在之前几天发生近期痛风发作的可能性明显更高。这些发现表明痛风发作与发作后心血管事件的短暂增加有关。